1. Why Myriad Genetics doesn’t care about the Supreme Court’s ruling [How legal woes can affect a company] Arden Perkins

2. Association for Molecular Pathology vs. Myriad Genetics & USPTO Myriad was awarded patents for 2 human genes ◦ Brca1, Brca2 Indicate susceptibility to breast cancer* http://www.youtube.com/watch?v=YTVW3uZSD1E

3. Ethical Issues Human genes are natural products ◦ Not patentable ◦ Have been patented for last 20 years! May hinder research progress ◦ Can’t improve technology ◦ Monopoly Scientists & civil rights groups challenged the patents

4. Supreme Court rules you can’t patent genes... But you can. http://www.youtube.com/watch?v=CYdNFF6qORw Strikes down gene patents But rules that cDNA is patentable ◦ Disconnect between scientists/legislation/politicians “Shares of Myriad Genetics (MYGN) popped nearly 11% to a four-year high in morning trading Thursday after the U.S. Supreme Court issued a mixed ruling on whether its genetic products could be patented.” –Investors.com

5. Other Biotech companies impacted by legal issues: Geron Inc. Stem Cells Inc. SAFC Must navigate a minefield of strange policies, some reasonable some not... If “benefits” of research are stripped from companies, will the motivation to develop them remain?

6. Sources http://mysticpolitics.com/insane-aclu-sues-myriad-genetics-patent-human-genes/ http://www.businessinsider.com/supreme-court-myriad-case-2013-4 http://www.bcaction.org/take-action/outlaw-human-gene-patents/